phase readout
saveNCT06698003: A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1
RECRUITINGupdated 2mo ago
community read0 votes
Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE2. Conditions: T-Cell Leukemia/Lymphoma, Adult, T-cell Leukemia/Lymphoma, T-cell Leukemia, Lymphoma
view source ↗
comments(0)
5-min edit window · permanent after that